And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

Higher mean blood pressure (BP) levels were associated with faster rates of visual field progression in patients with ...

The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning ...

Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...

Plaintiff attorney: My responsibility is to my client. I need to do the best I can. If the defense demands confidentiality ...